Boston Scientific Corporation
MX ˙ BMV ˙ FR0010424135
SecurityMX:BSX / Boston Scientific Corporation
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership678,172 shares
Latest Disclosed Value $ 42,555,293
Tocqueville Asset Management L.p. reports 52.84% increase in ownership of BSX / Boston Scientific Corporation

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 678,172 shares of Boston Scientific Corporation (MX:BSX) valued at $42,555,293 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 443,728 shares of Boston Scientific Corporation. This represents a change in shares of 52.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BOSTON SCIENTIFIC COM 101137107 678,172 234,444 52.84 42,555 0.58 0.6310
2026-02-12 2025-12-31 13F BOSTON SCIENTIFIC COM 101137107 443,728 -3,001 -0.67 42,309 -2.99 0.6172
2025-11-13 2025-09-30 13F BOSTON SCIENTIFIC COM 101137107 446,729 -28,466 -5.99 43,614 -14.55 0.6340
2025-08-12 2025-06-30 13F BOSTON SCIENTIFIC COM 101137107 475,195 -16,802 -3.42 51,041 2.84 0.7770
2025-05-13 2025-03-31 13F BOSTON SCIENTIFIC COM 101137107 491,997 -4,915 -0.99 49,633 11.82 0.8105
2025-02-10 2024-12-31 13F BOSTON SCIENTIFIC COM 101137107 496,912 -5,446 -1.08 44,384 5.43 0.6961
2024-11-08 2024-09-30 13F BOSTON SCIENTIFIC COM 101137107 502,358 1,079 0.22 42,098 9.05 0.6613
2024-08-12 2024-06-30 13F BOSTON SCIENTIFIC COM 101137107 501,279 -16,776 -3.24 38,603 8.80 0.6372
2024-05-09 2024-03-31 13F BOSTON SCIENTIFIC COM 101137107 518,055 -4,292 -0.82 35,482 17.50 0.5797
2024-02-12 2023-12-31 13F BOSTON SCIENTIFIC COM 101137107 522,347 -8,210 -1.55 30,197 7.79 0.5474
2023-11-09 2023-09-30 13F BOSTON SCIENTIFIC COM 101137107 530,557 -52,631 -9.02 28,013 -11.19 0.5320
2023-08-11 2023-06-30 13F BOSTON SCIENTIFIC COM 101137107 583,188 -4,878 -0.83 31,545 7.22 0.5648
2023-05-10 2023-03-31 13F BOSTON SCIENTIFIC COM 101137107 588,066 -37,765 -6.03 29,421 1.60 0.5558
2023-02-09 2022-12-31 13F BOSTON SCIENTIFIC COM 101137107 625,831 -11,125 -1.75 28,957 17.38 0.5500
2022-11-10 2022-09-30 13F BOSTON SCIENTIFIC COM 101137107 636,956 -113,975 -15.18 24,669 -11.86 0.5028
2022-08-12 2022-06-30 13F BOSTON SCIENTIFIC COM 101137107 750,931 -1,800 -0.24 27,987 -16.05 0.5118
2022-05-16 2022-03-31 13F Boston Scientific COM 101137107 752,731 8,630 1.16 33,338 5.47 0.5036
2022-02-14 2021-12-31 13F BOSTON SCIENTIFIC COM 101137107 744,101 4,475 0.61 31,609 -1.51 0.4348
2021-11-15 2021-09-30 13F BOSTON SCIENTIFIC COM 101137107 739,626 -204,920 -21.70 32,092 -20.54 0.4754
2021-08-16 2021-06-30 13F BOSTON SCIENTIFIC COM 101137107 944,546 -9,125 -0.96 40,389 9.58 0.5835
2021-05-17 2021-03-31 13F BOSTON SCIENTIFIC COM 101137107 953,671 96,159 11.21 36,859 19.56 0.5672
2021-02-16 2020-12-31 13F BOSTON SCIENTIFIC COM 101137107 857,512 272,950 46.69 30,828 38.02 0.5146
2020-11-16 2020-09-30 13F BOSTON SCIENTIFIC COM 101137107 584,562 -8,890 -1.50 22,336 7.20 0.4273
2020-08-12 2020-06-30 13F BOSTON SCIENTIFIC COM 101137107 593,452 593,452 20,836 0.4345
2020-05-15 2020-03-31 13F Boston Scientific COM 101137107 0 -21,600 -100.00 0 -100.00
2020-01-14 2019-12-31 13F Boston Scientific COM 101137107 21,600 -94,963 -81.47 977 -79.40 0.0144
2019-10-31 2019-09-30 13F Boston Scientific COM 101137107 116,563 4,178 3.72 4,743 -1.80 0.0644
2019-07-31 2019-06-30 13F Boston Scientific COM 101137107 112,385 -2,765 -2.40 4,830 9.30 0.0626
2019-04-30 2019-03-31 13F Boston Scientific COM 101137107 115,150 -16,710 -12.67 4,419 -5.17 0.0590
2019-02-08 2018-12-31 13F Boston Scientific COM 101137107 131,860 120,360 1,046.61 4,660 951.92 0.0698
2018-11-13 2018-09-30 13F Boston Scientific COM 101137107 11,500 11,500 443 0.0056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.